ProKidney Q3 EPS $(0.17) Misses $(0.14) Estimate, Sales $174.000K Beat $124.600K Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings BeatsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 41.67 percent decrease over losses of $(0.12) per share from the
ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 41.67 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $174.000 thousand which beat the analyst consensus estimate of $124.600 thousand by 39.65 percent. This is a 19.82 percent decrease over sales of $217.000 thousand the same period last year.
